Home / Workshop program

Workshop program

The event will operate on Queensland time / AEST / UTC+10h / GMT+10h

 
Friday the 24th of May 2024

The First International AIS School of Digital Immunohistochemistry
Time Title & Speaker Duration
8:00am – 8:15am Registration open (QLD time)
 		 –
8:15am – 8:30am Introduction.
Glenn Francis, President of the Australasian Immunohistochemistry Society		 15min
8:30am – 8:55am A short introduction to digital pathology/IHC: definition, key concepts, and clinical integration aspects
Eugen Petcu, The Australasian Immunohistochemistry Society NYIT-Histo Lab Core and Biomedical Sciences, Old Westbury, NY, USA
and Griffith University School of Medicine and Dentistry, Gold Coast Campus, Queensland, Australia
 25min
9:00am – 9:25am IHC Calibration and Control for Digital Analysis
Yukako Yagi, Department of Pathology, Warren Alpert Center for Digital
and Computational Pathology, Memorial Sloan Kettering, New York, NY, USA		 25min
9:30am – 9:55am Incorporating Digital Image Analysis into EQA.
Andrew Dodson, UK NEQAS for Immunocytochemistry and In-Situ Hybridization, London, United Kingdom		 25min
10:00am – 10:30am Coffee break
 		 30min
10:30am – 10:55am Automated HER2 assessment on H&E, IHC, and Dual ISH
Yukako Yagi, Department of Pathology, Warren Alpert Center for Digital
and Computational Pathology, Memorial Sloan Kettering, New York, NY, USA		 25min
11:00am – 11:30am Unlocking the power of H&E/IHC images: Predicting prognosis and treatment response using AI-based pathomics.
Ritu Aneja, School of Health Professions , The University of Alabama at Birmingham,
Birmingham, AL, USA
 25min
12:30pm – 1:30pm Lunch
 		 60min
 
Friday the 24th of May 2024

The Eighth International Workshop in Diagnostic Immunohistochemistry
1:30pm – 1:45pm Welcome message
Glenn Francis, President of the Australasian Immunohistochemistry Society		 15min
1:50pm – 2:35pm A Four Decade Journey Through Markers of Carcinomas of Unknown Primary – Keynote lecture
Allen Gown, Tumor markers and immunohistochemistry, Seattle, WA, United States
and The University of British Columbia, Vancouver, BC, Canada
 45min
2:40pm – 3:10pm How to solve melanocytic problems
Thomas Brenn, Department of Pathology, University of Michigan, Ann Arbor, MI, USA		 25min
3:15pm – 4:45pm The use of immunohistochemistry in era of molecular pathology
Fadia Mitali, ACT Pathology, Canberra Health Services
and Canberra Clinical School, ANU School of Medicine and Psychology, Canberra, Australia		 30min
6:00pm – late Cocktail Reception – sponsored by Agilent

 		 –
 
Saturday the 25th of May 2024

The Eighth International Workshop in Diagnostic Immunohistochemistry
Time Title & Speaker Duration
8:30am – 9:00am Registration open (QLD time)
 		 –
9:00am – 9:25am Technical test approach: the pre-analytical phase
Piero Nelva, Monash Medical Centre, Melbourne, VIC, Australia		 25min
9:30am – 9:55am Technical test approach: the analytical phase
Suzanne Parry, UK NEQAS for Immunocytochemistry and In-Situ Hybridisation, London, United Kingdom		 25min
10:00am – 10:25am Technical test approach: the post-analytical phase
Andrew Dodson, UK NEQAS for Immunocytochemistry and In-Situ Hybridisation, London, United Kingdom		 25min
10:30am – 11:00am Coffee break
 		 30min
11:00am – 11:25am An update on immunohistochemistry controls – Monash perspective
Piero Nelva, Monash Medical Centre, Melbourne, VIC, Australia		 25min
11:30am – 11:55am Dual immunohistochemical stains as diagnostic aids
Beena Kumar, The Australasian Immunohistochemistry Society
and Monash Medical Centre, Melbourne, VIC, Australia		 25min
12:00pm – 12:25pm Companion Diagnostic vs. Laboratory Developed Test: Experience from the UK NEQAS PD-L1 in Triple-Negative Breast Cancer EQA
Suzanne Parry, UK NEQAS for Immunocytochemistry and In-Situ Hybridisation, London, United Kingdom		 25min
12:30pm – 1:00pm Lunch
 		 30min
1:30pm – 1:55pm The role of immunohistochemistry in cytology
Julia Pagliuso, The Royal College of Pathologists of Australasia-Quality Assurance Programs (RCPA-QAP) – St Leonards NSW, Australia		 25min
2:00pm – 2:25pm Ki-67 as a prognostic marker in early hormone receptor-positive breast cancer
Andrew Dodson, UK NEQAS for Immunocytochemistry and In-Situ Hybridisation, London, United Kingdom		 25min
2:30pm – 2:55pm The Ki-67 Antigen Biomarker in Breast Cancer: Are We There Yet?
Allen Gown, Tumor markers and immunohistochemistry, Seattle, WA, United States
and The University of British Columbia, Vancouver, BC, Canada
 25min
3:00pm – 3:30pm Coffee break
 		 30min
3:30pm – 3:55pm Useful ancillary tools in the diagnosis of epithelioid vascular tumors
Thomas Brenn, Department of Pathology, University of Michigan, Ann Arbor, MI, USA		 25min
4:30pm – 4:55pm Fact or Fiction- Weird IHC Experiences
David Gan, The Australasian Immunohistochemistry Society and Princess Alexandra Hospital – Brisbane, QLD, Australia
and RCPA-QAP Team – St Leonards, NSW, Australia		 25min
6:00pm – Gala Dinner
 		 –
 
Sunday the 26th of May 2024

The Eighth International Workshop in Diagnostic Immunohistochemistry
Time Title & Speaker Duration
9:00am – 9:25am The role of IHC/IF in medical renal biopsies evaluation
Fadia Mitali, ACT Pathology, Canberra Health Services
and Canberra Clinical School, ANU School of Medicine and Psychology, Canberra, Australia		 25min
9:30am – 9:55am Immunohistochemistry – our friends or foes, case studies.
Beena Kumar, The Australasian Immunohistochemistry Society
and Monash Medical Centre, Melbourne, VIC, Australia		 25min
10:00am – 10:30am Coffee break
 		 30min
10:30am – 11:15am RCPA QAP: technical mock assessment
David Gan, The Australasian Immunohistochemistry Society and Princess Alexandra Hospital – Brisbane, QLD, Australia
and RCPA-QAP Team – St Leonards, NSW, Australia		 45min
11:20am – 11:30am Wrap-up message.
Glenn Francis, President of the Australasian Immunohistochemistry Society		 10min
11:30am – 12:00pm Farewell coffee, sandwiches, and cakes
 		 30min
 

Last update on: 2024/05/16 08:55:58 UTC/GMT time.